Erratum: Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells [Biomicrofluidics, 9, 5, (2015), (054110)] Doi: 10.1063/1.4930983;Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells

Biomicrofluidics

Volumn 9, Issue 5, 2015, Pages

  Maremanda, Nihal G ^a,b   Roy, Kislay ^a   Kanwar, Rupinder K ^a   Shyamsundar, Vidyarani ^c   Ramshankar, Vijayalakshmi ^d   Krishnamurthy, Arvind ^d   Krishnakumar, Subramanian ^e   Kanwar, Jagat R ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b Vimtalabs   (India)

^c Shree Balaji Dental College   (India)

^d CANCER INSTITUTE WIA   (India)

^e VISION RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; BLOOD; CELL ADHESION; COST EFFECTIVENESS; DECISION MAKING; DISEASES; FLUIDIC DEVICES; MICROCHANNELS; MICROFLUIDICS; NUCLEIC ACIDS; REUSABILITY; SILICONES; TUMORS;

CIRCULATING TUMOR CELLS; CLINICAL DECISION MAKING; EPITHELIAL CELL ADHESION MOLECULES; HEAD-AND-NECK CANCER; IMMUNOHISTOCHEMISTRY; MICRO-FLUIDIC DEVICES; SQUAMOUS CELL CARCINOMA; THERAPEUTIC EFFICACY;

DIAGNOSIS;

EID: 84943175267     PISSN: 19321058     EISSN: None     Source Type: Journal    
DOI: 10.1063/1.4999489     Document Type: Erratum

References (64)

1. D. T. Miyamoto, L. V. Sequist, and R. J. Lee, "Circulating tumour cells-Monitoring treatment response in prostate cancer," Nat. Rev. Clin. Oncol. 11, 401-41 (2014). 10.1038/nrclinonc.2014.82
2. C. Alix-Panabières and K. Pantel, "Circulating tumor cells: Liquid biopsy of cancer," Clin. Chem. 59, 110-118 (2013). 10.1373/clinchem.2012.194258
3. C. Alix-Panabières and K. Pantel, "Technologies for detection of circulating tumor cells: Facts and vision," Lab Chip 14, 57-62 (2014). 10.1039/C3LC50644D
4. A. Gröbe et al., "Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity," Clin. Cancer Res. 20, 425-433 (2014). 10.1158/1078-0432.CCR-13-1101
5. W. Sheng, T. Chen, W. Tan, and Z. H. Fan, "Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices," ACS Nano 7, 7067-7076 (2013). 10.1021/nn4023747
6. S. Riethdorf et al., "Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system," Clin. Cancer Res. 13, 920-928 (2007). 10.1158/1078-0432.CCR-06-1695
7. E. S. Lianidou, A. Strati, and A. Markou, "Circulating tumor cells as promising novel biomarkers in solid cancers," Crit. Rev. Clin. Lab. Sci. 51, 160-171 (2014)10.3109/10408363.2014.896316.
8. P. Li, Z. S. Stratton, M. Dao, J. Ritz, and T. J. Huang, "Probing circulating tumor cells in microfluidics," Lab Chip 13, 602-609 (2013). 10.1039/c2lc90148j
9. Y. Chen et al., "Rare cell isolation and analysis in microfluidics," Lab Chip 14, 626-645 (2014). 10.1039/c3lc90136j
10. K.-A. Hyun and H.-I. Jung, "Advances and critical concerns with the microfluidic enrichments of circulating tumor cells," Lab Chip 14, 45-56 (2014). 10.1039/C3LC50582K
11. A. G. Hovanessian et al., "The cell-surface-expressed nucleolin is associated with the actin cytoskeleton," Exp. Cell Res. 261, 312-328 (2000). 10.1006/excr.2000.5071
12. M. Srivastava and H. B. Pollard, "Molecular dissection of nucleolin's role in growth and cell proliferation: New insights," FASEB J. 13, 1911-1922 (1999); PMID: 10544174.
13. T. Watanabe et al., "Nucleolin on the cell surface as a new molecular target for gastric cancer treatment," Biol. Pharm. Bull. 33, 796-803 (2009). 10.1248/bpb.33.796
14. M. Herlyn, Z. Steplewski, D. Herlyn, and H. Koprowski, "Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies," Proc. Natl. Acad. Sci. U. S. A. 76, 1438-1442 (1979). 10.1073/pnas.76.3.1438
15. M. J. Winter, I. D. Nagtegaal, J. Van Krieken, and S. V. Litvinov, "The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology," Am. J. Pathol. 163, 2139-2148 (2003). 10.1016/S0002-9440(10)63570-5
16. P. T. Went et al., "Frequent EpCam protein expression in human carcinomas," Human Pathol. 35, 122-128 (2004). 10.1016/j.humpath.2003.08.026
17. P. Went et al. "Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers," Br. J. Cancer 94, 128-135 (2006). 10.1038/sj.bjc.6602924
18. J. E. Visvader and G. J. Lindeman, "Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions," Nat. Rev. Cancer 8, 755-768 (2008). 10.1038/nrc2499
19. B. T. F. van der Gun et al. "EpCAM in carcinogenesis: The good, the bad or the ugly," Carcinogenesis 31, 1913-1921 (2010). 10.1093/carcin/bgq187
20. D. Maetzel et al., "Nuclear signalling by tumour-associated antigen EpCAM," Nature Cell Biol. 11, 162-171 (2009). 10.1038/ncb1824
21. Z. Tang et al., "Selection of aptamers for molecular recognition and characterization of cancer cells," Anal. Chem. 79, 4900-4907 (2007). 10.1021/ac070189y
22. D. Shangguan et al., "Aptamers evolved from live cells as effective molecular probes for cancer study," Proc. Natl. Acad. Sci. 103, 11838-11843 (2006). 10.1073/pnas.0602615103
23. M. Famulok, G. Mayer, and M. Blind, "Nucleic acid aptamers from selection in vitro to applications in vivo," Acc. Chem. Res. 33, 591-599 (2000). 10.1021/ar960167q
24. A. Z. Wang and O. C. Farokhzad, "Current progress of aptamer-based molecular imaging," J. Nucl. Med. 55, 353-356 (2014). 10.2967/jnumed.113.126144
25. Y. Xu et al., "Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells," Anal. Chem. 81, 7436-7442 (2009). 10.1021/ac9012072
26. W. Sheng et al., "Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device," Anal. Chem. 84, 4199-4206 (2012). 10.1021/ac3005633
27. M. A. Campbell and J. Wengel, "Locked vs. unlocked nucleic acids (LNA vs. UNA): Contrasting structures work towards common therapeutic goals," Chem. Soc. Rev. 40, 5680-5689 (2011). 10.1039/c1cs15048k
28. R. N. Veedu and J. Wengel, "Locked nucleic acids: promising nucleic acid analogs for therapeutic applications," Chem. Biodivers. 7, 536-542 (2010). 10.1002/cbdv.200900343
29. D. Shangguan, Z. Tang, P. Mallikaratchy, Z. Xiao, and W. Tan, "Optimization and modifications of aptamers selected from live cancer cell lines," ChemBioChem 8, 603-606 (2007). 10.1002/cbic.200600532
30. J. R. Kanwar, K. Roy, and R. K. Kanwar, "Chimeric aptamers in cancer cell-targeted drug delivery," Crit. Rev. Biochem. Mol. Biol. 46, 459-477 (2011)10.3109/10409238.2011.614592.
31. I. Cima et al., "Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives," Biomicrofluidics 7, 011810 (2013). 10.1063/1.4780062
32. S. Shim et al., "Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis," Biomicrofluidics 7, 011807 (2013). 10.1063/1.4774304
33. H.-S. Moon et al., "Continual collection and re-separation of circulating tumor cells from blood using multi-stage multi-orifice flow fractionation," Biomicrofluidics 7, 014105 (2013). 10.1063/1.4788914
34. J. Sun et al., "Size-based hydrodynamic rare tumor cell separation in curved microfluidic channels," Biomicrofluidics 7, 011802 (2013). 10.1063/1.4774311
35. U. Marolt, A. Cencic, M. Gorenjak, and S. Potrc, "Generating aptamers for cancer diagnosis and therapy," Clin. Exp. Pharmacol. 2, 1-8 (2012)10.4172/2161-1459.1000111.
36. Y. Takei et al., "5'-,3'-inverted thymidine-modified antisense oligodeoxynucleotide targeting midkine: Its design and application for cancer therapy," J. Biol. Chem. 277, 23800-23806 (2002). 10.1074/jbc. M112100200
37. C. Marquette, I. Lawrence, C. Polychronakos, and M. Lawrence, "Impedance based DNA chip for direct Tm measurement," Talanta 56, 763-768 (2002). 10.1016/S0039-9140(01)00633-6
38. See supplementary material at http://dx.doi.org/10.1063/1.4930983E-BIOMGB-9-008505 for simultaneous characterization for multiple markers/proteins.
39. J. A. Phillips, Y. Xu, Z. Xia, Z. H. Fan, and W. Tan, "Enrichment of cancer cells using aptamers immobilized on a microfluidic channel," Anal. Chem. 81, 1033-1039 (2008). 10.1021/ac802092j
40. A. Armstrong and S. L. Eck, "EpCAM: A new therapeutic target for an old cancer antigen," Cancer Biol. Ther. 2, 320-325 (2003). 10.4161/cbt.2.4.451
41. M. Balzar, M. J. Winter, C. J. de Boer, and S. V. Litvinov, "The biology of the 17-1A antigen (Ep-CAM)," J. Mol. Med. (Berl) 77, 699-712 (1999). 10.1007/s001099900038
42. J. R. Kanwar, R. K. Kanwar, G. Mahidhara, and C. H. A. Cheung, "Cancer targeted nanoparticles specifically induce apoptosis in cancer cells and spare normal cells," Aust. J. Chem. 65, 5-14 (2012). 10.1071/CH11372
43. V. Dapic et al., "Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications," Biochemistry 41, 3676-3685 (2002). 10.1021/bi0119520
44. F. Mongelard and P. Bouvet, "AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia," Curr. Opin. Mol. Ther. 12, 107-114 (2010); PMID: 20140822.
45. S. Shigdar et al., "RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule," Cancer Sci. 102, 991-998 (2011). 10.1111/j.1349-7006.2011.01897.x
46. P. J. Bates, J. B. Kahlon, S. D. Thomas, J. O. Trent, and D. M. Miller, "Antiproliferative activity of G-rich oligonucleotides correlates with protein binding," J. Biol. Chem. 274, 26369-26377 (1999). 10.1074/jbc.274.37.26369
47. Q. Zhou et al., "Aptamer-containing surfaces for selective capture of CD4 expressing cells," Langmuir 28, 12544-12549 (2012). 10.1021/la2050338
48. U. Dharmasiri et al., "Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device," Electrophoresis 30, 3289-3300 (2009). 10.1002/elps.200900141
49. J. Zhu, T. Nguyen, R. Pei, M. Stojanovic, and Q. Lin, "Specific capture and temperature-mediated release of cells in an aptamer-based microfluidic device," Lab Chip 12, 3504-3513 (2012). 10.1039/c2lc40411g
50. K.-M. Song, S. Lee, and C. Ban, "Aptamers and their biological applications," Sensors 12, 612-631 (2012). 10.3390/s120100612
51. R. R. Breaker, "Natural and engineered nucleic acids as tools to explore biology," Nature 432, 838-845 (2004). 10.1038/nature03195
52. W. Sheng et al., "Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip," Lab Chip 14, 89-98 (2014). 10.1039/C3LC51017D
53. K. Farin et al., "Oncogenic synergism between ErbB1, nucleolin, and mutant Ras," Cancer Res. 71, 2140-2151 (2011). 10.1158/0008-5472.CAN-10-2887
54. X. Guo et al., "Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy," Diagn. Pathol. 9, 175 (2014). 10.1186/s13000-014-0175-y
55. E. M. Reyes-Reyes and S. K. Akiyama, "Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells," Exp. Cell Res. 314, 2212-2223 (2008). 10.1016/j.yexcr.2008.03.016
56. V. Schartinger et al., "The expression of EGFR, HER2 and EpCam in head and neck squamous cell carcinomas," memo-Mag. Eur. Med. Oncol. 2, 45-50 (2009). 10.1007/s12254-008-0082-6
57. H. J. Yoon et al., "Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets," Nat. Nanotechnol. 8, 735-741 (2013). 10.1038/nnano.2013.194
58. M. Schena et al., "Parallel human genome analysis: microarray-based expression monitoring of 1000 genes," Proc. Natl. Acad. Sci. 93, 10614-10619 (1996). 10.1073/pnas.93.20.10614
59. D. M. Walker, G. Boey, and L. McDonald, "The pathology of oral cancer," Pathology 35, 376-383 (2003). 10.1080/00310290310001602558
60. S. Warnakulasuriya, "Global epidemiology of oral and oropharyngeal cancer," Oral Oncol. 45, 309-316 (2009). 10.1016/j.oraloncology.2008.06.002
61. J. Kanwar and V. Vinayak, "The significance of free and immune-complexed hydatid-specific antigen (s) as an immunodiagnostic tool for human hydatidosis," J. Med. Microbiol. 37, 396-403 (1992). 10.1099/00222615-37-6-396
62. R. Miller and C. Estran, Heat-Induced Epitope Retrieval with a Pressure Cooker-Suggestions for Optimal Use (Lippincott-Raven Publ., 227 East Washington Sq, Philadelphia, PA 19106, 1995), Vol. 3, pp. 190-193.
63. A. J. Norton, S. Jordan, and P. Yeomans, "Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues," J. Pathol. 173, 371-379 (1994). 10.1002/path.1711730413
64. K. Roy et al., "Locked nucleic acid modified bi-specific aptamer-targeted nanoparticles carrying survivin antagonist towards effective colon cancer therapy," RSC Adv. 5, 29008-29016 (2015). 10.1039/C5RA03791C